CBD oil contains CBD mixed with an inert carrier oil, such as coconut oil or hemp seed oil. The bottled oil, called a tincture, is sold in various concentrations. There are also CBD capsules, CBD gummies, and under-the-tongue CBD sprays.
Outside of these two disorders, CBD’s effectiveness in treating seizures is uncertain. Even with Epidiolex, it is uncertain whether the anti-seizure effects can be attributed to CBD or some other factor.
Cathy Wong is a nutritionist and wellness expert. Her work is regularly featured in media such as First For Women, Woman's World, and Natural Health.
CBD oil may benefit those with drug addiction, suggests a 2015 review of studies published in Substance Abuse.
Among the few human trials evaluating CBD’s anxiolytic effects was one published in the Brazilian Journal of Psychiatry in 2019. For this study, 57 men were given either CBD oil or a placebo before a public-speaking event. Anxiety was evaluated using physiological measures (such as blood pressure, heart rate, etc.) and a relatively reliable test for mood states known as the Visual Analog Mood Scale (VAMS).
Couch DG, Cook H, Ortori C, Barrett D, Lund JN, O’Sullivan SE. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial. Inflamm Bowel Dis. 2019;25(6):1006-1018. View abstract.
Valvassori SS, Elias G, de Souza B, et al. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychopharmacol 2011;25(2):274-80. View abstract.
Zuardi AW, Rodriguez JA, Cunha JM. Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology (Berl) 1991;104(2):260-4. View abstract.
Possibly Effective for
Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med 2011;51(5):1054-61. View abstract.
Rosenkrantz H, Fleischman RW, Grant RJ. Toxicity of short-term administration of cannabinoids to rhesus monkeys. Toxicol Appl Pharmacol 1981;58(1):118-31. View abstract.
Yamaori S, Okamoto Y, Yamamoto I, Watanabe K. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos 2011;39(11):2049-56. View abstract.
Devinsky O, Verducci C, Thiele EA, et al. Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. Epilepsy Behav. 2018 Sep;86:131-137. Epub 2018 Jul 11. View abstract.
2020-02-25 2:00 AM EST
Vancouver, British Columbia–(Newsfile Corp. – May 11, 2020) – Hemp for Health Inc. (CSE: HFH) (FSE: 9HH) (“H4H” or the “Company”), a cultivator and distributor of premium “Made in Tuscany” CBD products, is pleased to announce that the start of the 2020 hemp planting season in Tuscany, Italy has begun.”The 2020 growing season has arrived in the Tuscan valley and we look forward to building on the progress we made with last year’s harvest,” commented Robert Eadie, President.
2020-02-10 9:00 AM EST
Vancouver, British Columbia–(Newsfile Corp. – February 25, 2020) – HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the “Company” or “HFH”), a cultivator and distributor of premium CBD products in Italy and other European countries, is pleased to announce that it has signed cultivation contracts with four different agriculture companies for the 2020 growing season.The contracts to cultivate hemp on approximately 150 Ha of farmland in the Sienna province of Italy are expected to yield approximately 100,000 kilos of biomass.
2021-05-31 11:00 AM EDT
Vancouver, British Columbia–(Newsfile Corp. – February 10, 2020) – HEMP FOR HEALTH INC. (CSE:HFH) (“H4H” or the “Company”), a cultivator and distributor of premium “Made in Tuscany” CBD products, is pleased to announce that its shares are now listed on the Frankfurt Stock Exchange (“FSE”) under symbol “9HH”.The Frankfurt Stock Exchange operated by Deutsche Börse Group is one of the world’s largest trading centers for securities and the largest of the eight stock exchanges in Germany. The.
Vancouver, British Columbia–(Newsfile Corp. – February 19, 2020) – HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the “Company”), a cultivator and distributor of premium CBD products in Italy and other European countries, is pleased to announce that it has arranged a non-brokered private placement of up to $2,000,000 (the “Financing”) through the issuance of up to 10,000,000 units (the “Units”) at a price of Vancouver, British Columbia–(Newsfile Corp. – February 12, 2020) – HEMP FOR HEALTH INC. (CSE: HFH) (FSE: 9HH) (the “Company”), a cultivator and distributor of premium CBD products in Italy and other European countries, wishes to provide its shareholders and potential investors with an update on 2019 operations and our 2020 growth expectations.Our first year of operations was focused on a test crop which included the CBD Carmagnola strain in the Tuscan valley. Of the 3 Ha of this strain..20 per Unit. Each Unit will be comprised of one common share and one-half.